Amrita University Launches Wearable For Home Monitoring of Glucose and Blood Pressure

Amrita University, India, has developed a device for home-monitoring of glucose and blood pressure.

Photo credit: Amrita University

Amrita University in Tamil Nadu, India, has developed a device for home-monitoring of glucose and blood pressure. Amrita Spandanam, as the device is called, will be sold online and through pharmacists across the country. The Tamil word ‘Spandanam’ means ‘beat’ in English.

Read more University of Arizona Researchers Develop Inexpensive Blood Pressure Monitoring System Using Pulse Wave Velocity

Developed and patented by the varsity’s Centre for Wireless Networks and Applications, it is a wearable, six-in-one device that is an excellent replacement for a bedside monitor. It can be used to measure six body parameters including blood glucose, blood pressure, heart rate, blood oxygen, respiratory rate, and 6-lead ECG, according to a press release.

“Amrita Spandanam is a revolutionary device that has bagged several US patents, with results published in top scientific journals. It offers a quick, easy, affordable and non-invasive way to monitor and detect diabetes, cardiovascular diseases, hypertension, sleep apnea and allergy attacks from the comfort of one’s home. The product was extensively tested on 1000 patients at Amrita Hospital in Kochi and various remote clinics in Kerala. Last year, these devices were successfully deployed at Amrita Hospital to remotely monitor the progression of severity in COVID-19 patients,” said Dr Maneesha V Ramesh, the Provost of Amrita University who led the team of researchers.

Amrita University Campus (PRNewswire photo)

Amrita Spandanam is connected to the patient’s smartphone. The data is sent to a secure hospital cloud which enables any doctor authorized by the patient to access the vital parameters remotely from any location. The product also integrates multiple -learning models that can predict the potential deterioration of patients’ health and provide early warning decision support to doctors for acute hypotensive episodes, sepsis, sleep apnea, and atrial fibrillation.

Read more Penn State Researchers Develop Wearable Non-Invasive Glucose Monitor

About Amrita University

Amrita partners with academic, industry and governmental institutions across the world to accomplish human-centered, translational, and groundbreaking research. Some of Amrita’s partners include Harvard University, Columbia University, King’s College London, KTH – Royal Institute of Technology, VU Amsterdam, the British Geological Society, University of Oxford, Italian National Research Council, Deakin University, and the University of Tokyo. Sri Mata Amritanandamayi Devi (Amma), a world-renowned humanitarian leader is the founder, Chancellor, and guiding light of Amrita University.

Sam Draper
March 16, 2022

Innovation of the Month

Do you want to discover more, visit the website
Visit Website

Other news

Coolpad Announces Fulfillment Partnership with Quality One for Dyno Smartwatch

Coolpad announced fulfillment partnership with Quality One Wireless for Dyno Smartwatch.

Neurolief’s Relivion Provides Significant Pain Reduction in Migraine Patients, Clinical Trial Finds

Neurolief’s Relivion™ wearable headband provides significant pain reduction.

Biofourmis Surpasses Unicorn Status

Today, Biofourmis announced it has surpassed unicorn status with a $300 million Series D investment.

IEEE Organization Announces Formation of LaSAR Alliance For AR Wearables

The IEEE Industry Standards and Technology Organization (ISTO), an international federation of...
Discover more